Bristol-Myers Squibb, Cerner, General Motors, Monsanto: Fast Money Picks For November 25

On CNBC's Fast Money Final Trade, Tim Seymour said that General Motors Company GM is cheap enough to buy. He added that the October sales were good.

David Seaburg believes Bristol-Myers Squibb Co BMY is worth buying at its current price.

Steve Grasso thinks that the merger between Monsanto Company MON and Bayer could be back on. If it goes through, there is tremendous upside potential.

Guy Adami is a buyer of Cerner Corporation CERN.